Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Dr. Martens plunges after fresh profit warning

Published 01/19/2023, 03:05 AM
Updated 01/19/2023, 03:56 AM
© Reuters

By Geoffrey Smith 

Investing.com -- Dr. Martens (LON:DOCS) stock plunged at the open on Thursday to a new all-time low, after the bootmaker was forced to cut its forecasts once again in response to problems in North America.

Dr. Martens said a variety of operational problems had created a bottleneck at its new distribution center in Los Angeles, leaving U.S. sales well below expectations in the third quarter of its fiscal year. As a result, it now expects revenue to grow by around only 12%, rather than the "high teens" percentage it had forecast at the start of the year.

Likewise, it now expects earnings before interest, taxes, depreciation, and amortization to be between £250-260 million (£1 = $1.2315), reflecting a hit of between £16-25M to EBITDA from the problems in Los Angeles. The problems are likely to continue into the new fiscal year starting in April, but "should normalize" by October, it said.  

Analysts had expected full-year EBITDA to be around £285M.

Ironically, the bottleneck at LA was caused by the easing of others elsewhere: inbound shipping times shortened significantly during the quarter, resulting in inventory arriving more quickly than anticipated. However, U.S. wholesalers reacting to signs of a consumer slowdown were unable to take the new inventory as quickly as the company had thought. A planned transfer of inventory from a distribution center in Portland also went faster than expected, leading to shoes piling up in LA instead.  

Dr. Martens had already signaled in November that its direct-to-consumer business had been suffering as demand weakened but had nonetheless plowed ahead with heavy investment spending and raised its interim dividend. 

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In the three months through December, sales slowed further. Group revenue rose only 3% in constant currencies from a year earlier, but it was the wholesale business, rather than DTC, which fared worst, with sales actually down 1%. 

Dr. Martens' stock fell as much as 28% initially but had recovered a little by 03:55 ET (08:55 GMT) to trade down "only" 21.2%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.